CGuard - Model EPS - Embolic Prevention System
CGuard EPS is designed to prevent peri-procedural and late embolisation by trapping potential emboli against the arterial wall while maintaining perfusion to the external carotid artery. Data from the PARADIGM-Extend study in patients with symptomatic or increased-stroke-risk asymptomatic carotid stenosis demonstrate sustained embolic protection with CGuard EPS over a 48-month follow-up period.
-
Most popular related searches
What makes CGuardTM (EPS) unique?
- Dual Layer Design
- Combines the largest open-cell frame of available carotid stents with the smallest mesh pore size..
- MicroNet®v
- Prevents plaque protusion through the stent, for lasting embolic protection demonstrated for up to 48 months.
- SmartFit TM technology
- Eliminates the need for tapered version and supports accurate vessel wall apposition.
Details
CGuardTM EPS is designed to reduce the risk of both early and late embolism
CGuardTM EPS is designed to prevent peri-procedural and late embolisation by trapping potential emboli against the arterial wall while maintaining perfusion to the external carotid artery.
Data from the PARADIGM-Extend study in patients with symptomatic or increased-stroke-risk asymptomatic carotid stenosis demonstrate sustained embolic protection with CGuardTM EPS over a 48-month follow-up period.
The rapid exchage (Rx) system delivers the self-expanding CGuardTM EPS to the carotid artery where it adapts to the vessel diameter, eliminating the need for a tapered design.2,3
CGuardTM EPS in action
InspireMD has established CGuardTM Centers of Excellence at leading hospitals in Europe to help educate and share experiences with CGuardTM through workshops and live cases.
Watch case studies of CGuardTM EPS implantation performed at our Centers of Excellence.
Product Details:
- Indications: The CGuardTM EPS is indicated for improving carotid luminal diameter in patients at high risk for adverse events from carotid endarterectomy who require carotid revascularisation and meet both the following criteria: Patients with neurological symptoms and >50% stenosis of the common or internal carotid artery by either ultrasound or angiogram OR patients without neurological symptoms and >80% stenosis of the common or internal carotid artery by either ultrasound or angiogram; and patients having a vessel with reference diameters between 4.8 mm and 9.0 mm at the target lesion.
- CGuardTM material: Nitinol
- MicroNet® material: Polyethylene Terephthalate (PET)
Customer reviews
No reviews were found for CGuard - Model EPS - Embolic Prevention System. Be the first to review!